What top creators are saying about Legend Biotech Corporation(LEGN)

Biotechnology company developing cell therapies for cancer.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Legend Biotech Corporation.

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering Legend Biotech Corporation (LEGN)

The 1 sources with the most insights about Legend Biotech Corporation on Kazuha.

@realmartinshkreli
@realmartinshkreli
YouTube·1 insight

Latest insights about Legend Biotech Corporation (LEGN)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral

Mentioned among biotech fund holdings; no company-specific investment analysis was provided.

Martin Shkreli
11/9/26 - wassup fellow spy
Martin ShkreliYouTube1 hour ago

Discussed alongside Legend Biotech Corporation (LEGN)

Other assets that creators frequently mention in the same content as Legend Biotech Corporation.

BHVNBiohaven Ltd.1×SFTBYSoftBank Group Corp.1×CGONCG Oncology, Inc.1×ERASErasca, Inc.1×ACADAcadia Pharmaceuticals Inc.1×SLSSELLAS Life Sciences Group, Inc.1×

Frequently asked

Which podcasters and creators cover Legend Biotech Corporation (LEGN) the most?

The most active sources covering Legend Biotech Corporation (LEGN) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Legend Biotech Corporation (LEGN) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Legend Biotech Corporation (LEGN) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Legend Biotech Corporation (LEGN)?

Creators covering Legend Biotech Corporation (LEGN) most frequently also discuss BHVN, SFTBY, CGON, ERAS, ACAD. See the "Discussed alongside" section above for full asset pages.